| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $303K | +17.4% | +29.5% |
| R&D Expense | $14.2M | -10.6% | +25.8% |
| SG&A Expense | $5.6M | +28.0% | +38.9% |
| Operating Income | -$19.5M | +2.5% | -29.3% |
| Pre-tax Income | -$18.9M | +2.7% | -34.1% |
| Income Tax | $0 | — | — |
| Net Income | -$18.9M | +2.7% | -34.1% |
| EPS (Basic) | -$0.45 | +16.7% | +2.2% |
| EPS (Diluted) | -$0.45 | +16.7% | +2.2% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $47.4M | -24.6% | -36.6% |
| Current Assets | $63.2M | -19.9% | -29.7% |
| Total Assets | $65.1M | -19.6% | -29.5% |
| Current Liabilities | $13.5M | -0.8% | +40.6% |
| Total Liabilities | $14.1M | -3.1% | +26.4% |
| Stockholders' Equity | $50.9M |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$50.2M | — | — |
| Investing Cash Flow | -$778K | — | — |
| Financing Cash Flow | $31.3M | — | — |
| -37.2% |